Dr. Ethan B. Fram, MD

Dr. Fram practices at Salem Hospital in Salem, Oregon, part of Salem Health Hospitals and Clinics.

Dr. Fram's NPI, 1851754337, was assigned on April 1, 2016. Dr. Fram holds Oregon license 203154.

Dr. Fram's primary practice is Salem Hospital, at 890 Oak Street, SE, Salem, OR 97301 in Marion County. The practice phone is (503) 561-5200.

Dr. Fram's primary practice is Salem Hospital in Salem, Oregon, part of Salem Health Hospitals and Clinics. Dr. Fram is also affiliated with Legacy Meridian Park Medical Center. The medical group on file is Salem Health. Dmand AI also links Dr. Fram to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Fram's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fram practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fram's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Fram is licensed in Oregon.

CMS data shows 334 Medicare services from Dr. Fram across 10 procedure codes in 2024, for 131 Medicare patients. Medicare paid $20,679 for them. Every service was in an office.

CMS counts 131 Medicare patients who saw Dr. Fram in 2024. The largest group is 65 to 74, with 70 patients. 67% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fram's median patient age at 72, with 24% women.

In 2024, Dr. Fram wrote 1,067 Medicare Part D claims for 382 patients. 75% of them were for generic drugs. CMS names the drug for 945 of them, across 19 drugs with 11 or more claims each, at $248,626 in total drug cost. In 2023, CMS named 1,184 claims across 20 drugs.

Dr. Fram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Fram, published from 2015 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Body Mass Index and Kidney Neoplasms. Dr. Fram has published most often in Clin Genitourin Cancer. Dr. Fram's most frequent co-authors are Kara L. Watts, MD, Ahmed Abdelrahim Mohamed Aboumohamed, MD and Alexander Ivan Sankin.

CMS Open Payments shows 42 general payments to Dr. Fram from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 86% of the total. Astellas Pharma US Inc paid the most, $371.